[1] Rezende NA, Blunverg HM, Metzger BZ, et al. Risk factors for methicillin resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission [J].Am J Med Sci, 2002, 323(3):117-123. [2] 陈智鸿, 吕晓菊, 范昕建, 等.金黄色葡萄球菌耐药 性监测 [J].中国抗感染化疗杂志, 2003, 3(1):13-15. [3] 朱德妹, 汪复, 张婴元, 等.2005 年上海地区细菌耐 药性监测 [J].中国感染与化疗杂志, 2006, 6(6): 371-378. [4] 王辉, 孙宏莉, 陈民钧, 等.2005 年我国五家教学医院革兰阳性球菌耐药监测研究 [J].中华检验医学杂志, 2006, 29(10):873-878. [5] Shopsin B, Kreiswirth BN.Molecular epidemiology of methicillin-resistant Staphylococcus aureus [J].Emerg Infect Dis, 2001, 7(2):323-326. [6] 马越, 陈鸿波, 姚蕾, 等.耐甲氧西林金黄色葡萄球 菌对万古霉素敏感性的变迁 [J].中华内科杂志, 2002, 41(1):31-36. [7] Moise PA, Schentag JJ.Vancomy cint reatment failures in Staphylococcus aureus lower respiratory tract infections [J].Int J Antimicrob Agents, 2000, 16 (Suppl 1):S31-S34. [8] Tsiodras S, Gold HS, Sakoulas G, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus [J]. Lancet, 2001, 358(9277):207-208. [9] Pillai SK, Sakoulas G, Wennersten C, et al. Linezolid resistance in Staphylococcus aureus:characterization and stability of resistant phenotype [J].J Infect Dis, 2002, 186 (11):1603-1607. [10] Wilson P, Andrews JA, Charlesworth R, et al. Linezolid resistance in clinical isolates of Staphylococcus aureus [J]. J Antimicrob Chemother, 2003, 51(1):186-191. |